Cargando…
Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator
While adjuvant treatments of early breast cancers (BCs) had significantly improved patients’ overall survival, some of them will still develop locoregional relapses and/or severe late radio-induced toxicities. Here, we propose to review how to personalize locoregional treatment by identifying patien...
Autores principales: | Azria, David, Brengues, Muriel, Gourgou, Sophie, Bourgier, Celine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895767/ https://www.ncbi.nlm.nih.gov/pubmed/29675397 http://dx.doi.org/10.3389/fonc.2018.00083 |
Ejemplares similares
-
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
por: Prunaretty, Jessica, et al.
Publicado: (2023) -
One Size Fits All: Does the Dogma Stand in Radiation Oncology?
por: Azria, David, et al.
Publicado: (2016) -
Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management
por: Quesada, Stanislas, et al.
Publicado: (2022) -
Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity
por: Lacombe, Jérôme, et al.
Publicado: (2019) -
Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology
por: Bourgier, Céline, et al.
Publicado: (2010)